Trial intelligence / Profile preview

Dexmedetomidine in patients undergoing coronary artery bypass graft surgery

PACTR201806003460336Completed

Sponsor
Palesa Mot
Start
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

Trial of dexmedetomidine in coronary arteriosclerosis (2 arms), sponsored by Palesa Mot. Primary endpoint: hs-cTnT. Started Feb 2014; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on PACTR201806003460336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201806003460336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call